Live from the NIH registry
Studies recruiting near Waco right now
Top 25 of 53 recruiting studies, sorted by proximity — each links to its official registry page
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: Akero Therapeutics, Inc
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
ActiveTherapy Alliance — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Waco Cardiology — Waco, Texas (2.6 mi)
· Sponsor: Alleviant Medical, Inc.
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Texas Oncology - Central South — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Waco, Texas (2.6 mi)
· Sponsor: Alnylam Pharmaceuticals
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Waco, Texas (2.6 mi)
· Sponsor: DalCor Pharmaceuticals
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
Post-operative Pain Management
N/A
Interventional 148 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: University of California, Los Angeles
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 582 participants sought
Research Site — Woodway, Texas (3.9 mi)
· Sponsor: AstraZeneca
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Primary Biliary Cholangitis, PBC
Phase 2
Interventional 260 participants sought
Impact Research — Waco, Texas (2.6 mi)
· Sponsor: Mirum Pharmaceuticals, Inc.
A Computerized Depression Intervention in Veterans
Depression
N/A
Interventional 152 participants sought
Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX — Waco, Texas (2.6 mi)
· Sponsor: VA Office of Research and Development
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: 89bio, Inc.
BOOM-IBD2 Pivotal Clinical Trial
Ulcerative Colitis, Inflammatory Bowel Diseases
N/A
Interventional 137 participants sought
Digestive Research of Central Texas (Objective Health) — Waco, Texas (2.6 mi)
· Sponsor: Boomerang Medical
National Sponsorship Program for Transitioning Service Members
Reintegration Difficulties, Health
N/A
Interventional 630 participants sought
Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX — Waco, Texas (2.6 mi)
· Sponsor: VA Office of Research and Development
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ulcerative Colitis, Crohn's Disease
Phase 4
Interventional 200 participants sought
Digestive Research of Central Texas, LLC — Waco, Texas (2.6 mi)
· Sponsor: Takeda
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Texas Oncology- Central South — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: 89bio, Inc.
Reliability and Validity of the PReFS
Neurologic Disorders, Spinal Cord Injury
N/A
Observational 15 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: Akero Therapeutics, Inc
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Primary Sjogren's Disease
Phase 3
Interventional 250 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Vor Biopharma
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis (PBC)
Phase 3
Interventional 276 participants sought
Impact Research Tx — Waco, Texas (2.6 mi)
· Sponsor: Ipsen
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Coronary Artery Disease
N/A
Observational 2,000 participants sought
Providence Health Center — Waco, Texas (2.6 mi)
· Sponsor: Minneapolis Heart Institute Foundation
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Texas Oncology - Central/South Texas — Waco, Texas (2.6 mi)
· Sponsor: Pfizer